When the deal closes, the combined company will take the BridgeBio Oncology Therapeutics name and is expected to trade on the Nasdaq under the stock symbol “BBOT.” BridgeBio Oncology aims to ...

In a move straight out of 2021, BridgeBio Oncology is taking the SPAC route to the public markets in a deal with Helix ...

Clinical-stage BridgeBio Oncology Therapeutics, whose financial backers include Cormorant Asset Management, is going public ...

Plus: Maura Healey meets with eds-and-meds leaders about threats to research funding; Takeda sends zebras flying at Celtics ...

“Late last year, my mother was diagnosed with lung cancer. We were very blessed that ... we are offering a tangible symbol of progress and a source of inspiration for those facing this extremely ...

As one of the leading causes of death worldwide, cancer and its many types have cut many lives short -- some of whom were ...

Nells Nelson founder Sisi Li didn't know that a childhood bout with rheumatic fever had damaged her heart — and she continued ...

“Late last year, my mother was diagnosed with lung cancer. We were very blessed that ... we are offering a tangible symbol of progress and a source of inspiration for those facing this extremely ...

a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor ...

Acasunlimab for solid tumors and non-small cell lung cancer (NSCLC); Rinatabart Sesutecan for platinum resistant ovarian cancer and solid tumors; GEN1042, GEN1059, GEN1055, and GEN1057 for solid ...

Free-speech battles and pressure from Washington threaten America’s oldest university—and the soul of higher education.

An environmental catastrophe is unfolding in the Kalabari Kingdom, Rivers State, where an unchecked oil spill has poisoned ...